Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study

Children and adolescents with allergic rhinitis and/or asthma should be prescribed montelukast with caution considering clinical benefits.

Authors

Institutions

Publication Details

Journal
BMJ Paediatrics Open
Published
2024-09-01
DOI
https://doi.org/10.1136/bmjpo-2023-002483
Citations
8
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
2.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study

Myeong Seong Kim, Ju‐Young Shin, Min Sook Seo, Jae Won Kim
8 citations
BMJ Paediatrics Open
Asthma and respiratory diseases
2.61
article

Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study

Myeong Seong Kim, Ju‐Young Shin, Min Sook Seo, Jae Won Kim
article en
8 citations

Abstract

Children and adolescents with allergic rhinitis and/or asthma should be prescribed montelukast with caution considering clinical benefits.

BMJ Paediatrics OpenVol. 8(1)
Samsung Medical Center (KR), Sungkyunkwan University (KR)
National Research Foundation, Sungkyunkwan University, National Research Foundation of Korea, Ministry of Education, India
Good health and well-being
Openalex Percentile: Top 10%
Asthma and respiratory diseases
2.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.